- Home
- EHC vs BRKR Comparison
EHC vs BRKR Comparison
Compare EHC & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EHC
- BRKR
- Stock Information
- Founded
- EHC 1983
- BRKR 1991
- Country
- EHC United States
- BRKR United States
- Employees
- EHC N/A
- BRKR N/A
- Industry
- EHC Hospital/Nursing Management
- BRKR Biotechnology: Laboratory Analytical Instruments
- Sector
- EHC Health Care
- BRKR Industrials
- Exchange
- EHC Nasdaq
- BRKR Nasdaq
- Market Cap
- EHC 9.5B
- BRKR 9.8B
- IPO Year
- EHC 1986
- BRKR 2000
- Fundamental
- Price
- EHC $96.88
- BRKR $60.49
- Analyst Decision
- EHC Strong Buy
- BRKR Buy
- Analyst Count
- EHC 8
- BRKR 11
- Target Price
- EHC $104.13
- BRKR $79.60
- AVG Volume (30 Days)
- EHC 576.6K
- BRKR 1.3M
- Earning Date
- EHC 10-28-2024
- BRKR 10-31-2024
- Dividend Yield
- EHC 0.70%
- BRKR 0.33%
- EPS Growth
- EHC 25.88
- BRKR 10.49
- EPS
- EHC 3.92
- BRKR 2.39
- Revenue
- EHC $5,070,900,000.00
- BRKR $3,119,700,000.00
- Revenue This Year
- EHC $11.83
- BRKR $17.05
- Revenue Next Year
- EHC $9.01
- BRKR $9.28
- P/E Ratio
- EHC $24.70
- BRKR $25.29
- Revenue Growth
- EHC 10.86
- BRKR 14.93
- 52 Week Low
- EHC $57.55
- BRKR $53.79
- 52 Week High
- EHC $98.74
- BRKR $94.86
- Technical
- Relative Strength Index (RSI)
- EHC 61.94
- BRKR 33.55
- Support Level
- EHC $92.93
- BRKR $63.28
- Resistance Level
- EHC $98.74
- BRKR $65.25
- Average True Range (ATR)
- EHC 1.37
- BRKR 2.05
- MACD
- EHC 0.09
- BRKR -0.75
- Stochastic Oscillator
- EHC 67.99
- BRKR 2.85
About EHC Encompass Health Corporation
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from Asia Pacific.